Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy

Detalles Bibliográficos
Autores principales: Wardell, Suzanne E., Yllanes, Alexander P., Chao, Christina A., Bae, Yeeun, Andreano, Kaitlyn J., Desautels, Taylor K., Heetderks, Kendall A., Blitzer, Jeremy T., Norris, John D., McDonnell, Donald P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997263/
https://www.ncbi.nlm.nih.gov/pubmed/31734822
http://dx.doi.org/10.1007/s10549-019-05498-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997263/
https://www.ncbi.nlm.nih.gov/pubmed/31734822
http://dx.doi.org/10.1007/s10549-019-05498-0

Ejemplares similares